Zoetis (ZTS) Stock Forecast & Price Target $161.77 -2.88 (-1.75%) Closing price 04/1/2025 03:59 PM EasternExtended Trading$161.70 -0.07 (-0.04%) As of 04/1/2025 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Zoetis - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating BuyBased on 12 Analyst RatingsSell0Hold1Buy11 Based on 12 Wall Street analysts who have issued ratings for Zoetis in the last 12 months, the stock has a consensus rating of "Buy." Out of the 12 analysts, 1 has given a hold rating, 9 have given a buy rating, and 2 have given a strong buy rating for ZTS. Consensus Price Target $215.9033.46% Upside According to the 12 analysts' twelve-month price targets for Zoetis, the average price target is $215.90. The highest price target for ZTS is $244.00, while the lowest price target for ZTS is $180.00. The average price target represents a forecasted upside of 33.46% from the current price of $161.77. Get the Latest News and Ratings for ZTS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Zoetis and its competitors. Enter your email to sign up for newsletter Sign Up ZTS Analyst Ratings Over TimeTypeCurrent Forecast4/2/24 to 4/2/251 Month Ago3/3/24 to 3/3/253 Months Ago1/3/24 to 1/2/251 Year Ago4/3/23 to 4/2/24Strong Buy2 Strong Buy rating(s)2 Strong Buy rating(s)2 Strong Buy rating(s)0 Strong Buy rating(s)Buy9 Buy rating(s)9 Buy rating(s)8 Buy rating(s)8 Buy rating(s)Hold1 Hold rating(s)1 Hold rating(s)1 Hold rating(s)0 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$215.90$215.90$215.22$222.11Forecasted Upside33.46% Upside26.65% Upside32.35% Upside34.60% UpsideConsensus RatingBuyBuyBuyBuy Remove Ads ZTS Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History ZTS Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Zoetis Stock vs. The CompetitionTypeZoetisMedical CompaniesS&P 500Consensus Rating Score 3.08 2.82 2.54Consensus RatingBuyModerate BuyModerate BuyPredicted Upside33.46% Upside19,857.29% Upside19.03% UpsideNews Sentiment RatingVery Positive NewsSee Recent ZTS NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails2/27/2025Piper Sandler2 of 5 starsDavid WestenbergSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOverweight ➝ Overweight$200.00 ➝ $205.00+24.25%2/14/2025Barclays3 of 5 starsBalaji PrasadSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOverweight ➝ Overweight$242.00 ➝ $244.00+52.72%2/14/2025Morgan Stanley3 of 5 starsErin WrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetOverweight ➝ Overweight$243.00 ➝ $238.00+49.95%1/7/2025Stifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetBuy ➝ Buy$210.00 ➝ $180.00+9.13%12/9/2024UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageNeutral$196.00+10.04%12/2/2024Leerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingD. ClarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy12/2/2024Leerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageOutperform$215.00+22.68%10/11/2024JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOverweight ➝ Overweight$225.00 ➝ $230.00+20.70%8/12/2024BTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. MassaroSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetBuy ➝ Buy$220.00 ➝ $225.00+22.75%8/9/2024ArgusSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. HellwegSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy Get the Latest News and Ratings for ZTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zoetis and its competitors with MarketBeat's FREE daily newsletter. 5/8/2024HSBCSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetBuy ➝ Buy$230.00 ➝ $225.00+36.80%5/6/2024The Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetBuy ➝ Buy$223.00 ➝ $196.00+17.58%12/19/2023Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy$230.00+16.03%12/7/2023BNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageOutperform$237.00+30.22%4/11/2023Bank Of America (Bofa)Subscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetBuy ➝ Buy$180.00 ➝ $200.00+16.74%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 01:21 AM ET. Should I Buy Zoetis Stock? ZTS Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, March 29, 2025. Please send any questions or comments about these Zoetis pros and cons to contact@marketbeat.com. Zoetis Bull Case Here are some ways that investors could benefit from investing in Zoetis Inc.: Zoetis Inc. has received multiple upgrades from analysts, with Piper Sandler raising their target price to $205.00 and StockNews.com upgrading their rating to "buy," indicating strong market confidence in the company's future performance. The average target price for Zoetis Inc. is currently $215.90, suggesting potential upside for investors based on current trading levels. As of now, the stock price is $163.03, which is below the average target price, presenting a buying opportunity for investors looking for growth. Zoetis Inc. has a solid market capitalization of $73.00 billion, reflecting its strong position in the animal health industry and providing stability for investors. The company has a relatively low debt-to-equity ratio of 1.09, indicating a balanced approach to leveraging, which can be a sign of financial health and lower risk for investors. Zoetis Bear Case Investors should be bearish about investing in Zoetis Inc. for these reasons: Recent insider selling, including a director selling 1,210 shares, may raise concerns about the company's future prospects and could indicate a lack of confidence from those within the company. The stock has experienced a decline of 1.2% recently, which may suggest volatility and potential challenges in maintaining its current price level. With a price-to-earnings ratio of 29.80, the stock may be considered overvalued compared to industry peers, which could deter value-focused investors. The company's beta of 0.94 indicates that it is less volatile than the market, which may not appeal to investors seeking high-risk, high-reward opportunities. Despite the positive ratings, the presence of a hold rating from one analyst suggests that not all market participants are convinced of the stock's potential, indicating mixed sentiment. ZTS Forecast - Frequently Asked Questions What is Zoetis' forecast for 2025? According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Zoetis is $215.90, with a high forecast of $244.00 and a low forecast of $180.00. Should I buy or sell Zoetis stock right now? 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zoetis in the last twelve months. There is currently 1 hold rating, 9 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ZTS shares. Does Zoetis's stock price have much upside? According to analysts, Zoetis's stock has a predicted upside of 33.46% based on their 12-month stock forecasts. What analysts cover Zoetis? Zoetis has been rated by research analysts at Barclays, Morgan Stanley, Piper Sandler, and Stifel Nicolaus in the past 90 days. Do Wall Street analysts like Zoetis more than its competitors? Analysts like Zoetis more than other "medical" companies. The consensus rating for Zoetis is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ZTS compares to other companies. Stock Forecasts and Research Tools Related Companies MRK Stock Forecast PFE Stock Forecast BMY Stock Forecast RPRX Stock Forecast CORT Stock Forecast JAZZ Stock Forecast PRGO Stock Forecast SUPN Stock Forecast PCRX Stock Forecast OMER Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:ZTS) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zoetis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zoetis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
